
Blood test detects early signs of breast cancer recurrence
Researchers at Lund University have developed a blood test capable of detecting signs of breast cancer recurrence long before recurrence becomes visible on imaging or causes symptoms.

Researchers at Lund University have developed a blood test capable of detecting signs of breast cancer recurrence long before recurrence becomes visible on imaging or causes symptoms.

Gene editing may help people born with dangerously high cholesterol lower their levels with just one infusion.

SINGAPORE, May 27, 2026 /PRNewswire/ — Gene Solutions, a global biotechnology company advancing accessible genomic solutions for cancer detection and precision oncology, today announced that the U.S. Food and Drug Administration has granted Breakthrough Device Designation to SPOT-MAS 10, its multi-omic blood test designed to detect cancer-associated signals.

A new map of the human eye made using donated eyeballs that could help explain and possibly prevent a handful of sight-related diseases.

DNA can be exchanged between two cells that connect by forming nanotubes, and find out why this is crucial for cancer research.

In a world first, a research team at the University of Zurich has successfully treated mice carrying an inherited form of epilepsy.

The study, published in Alzheimer’s & Dementia, showed that having a biological age older than chronological age is associated with a greater likelihood of developing dementia, particularly vascular dementia, and with an earlier age of onset across dementia subtypes.

Glioblastoma is one of the deadliest forms of brain cancer, and despite surgery, radiation, and chemotherapy, the disease almost always returns. Part of the reason is that these tumors are remarkably good at evading the immune system.

Now, a team of researchers from Memorial Sloan Kettering Cancer Center (MSK) has developed a new type of CAR T cell therapy that targets a protein found almost exclusively on leukemia cells and not on healthy cells.

Researchers at Washington University School of Medicine in St. Louis, showed that a stem cell transplant in which the donor cells have been genetically engineered to remove a particular protein helps prevent toxic side effects and potentially improves the effectiveness of therapies given after a transplant to help prevent cancer recurrence.